TARO-TERCONAZOLE
TARO-TERCONAZOLE
Approved
DIN Number
02247651
Drug Class
Human
Market Date
Sep 21, 2004
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02247651
AIG Number0122582001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G01AG02 TERCONAZOLE
Product Specifications
Dosage FormCream
Route of AdministrationVaginal
AHFS Classification84:04.08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
TERCONAZOLEActive
Strength: 0.4 %
Monograph: TERCONAZOLE